Anti-inflammatory drugs did not speed COVID-19 recovery but prevented deaths

View Content

Study could expand treatment options for patients with severe COVID-19

Two drugs commonly used to treat inflammatory diseases such as rheumatoid arthritis and psoriasis did not shorten recovery time for patients hospitalized with severe COVID-19 but did reduce the likelihood of death when compared with standard care alone, according to a national study led by Washington University School of Medicine in St. Louis.